Terminal Sterilization: Overkill vs Bioburden-Based Approaches
Terminal Sterilization: Overkill vs Bioburden-Based Approaches Terminal Sterilization: Understanding Overkill and Bioburden-Based Strategies in Pharmaceutical Manufacturing Ensuring sterility assurance is fundamental for pharmaceutical manufacturers engaged in sterile product fabrication. Both the United States Food and Drug Administration (FDA) and European Medicines Agency (EMA), among other global regulatory bodies, emphasize validated and robust sterilization processes aligned…
Read More “Terminal Sterilization: Overkill vs Bioburden-Based Approaches” »